Ruxolitinib
compare suppliers & send inquiries for free
Filters
Reset
Selected filters:
Type
Region
Qualifications
Country of origin
Distributor

Fast Response and Good Communication

Willingness To Start From Small

Flexible Payment Terms
+ 0
All certificates
Send inquiry
Replies in a day or 2
Producer
Produced in:
Established in: 2019
MOQ: 1 kg
Employees: 10+

Focused on pharmaceutical industry

Reasonable price for the customers

Full service from R&D stage to commercial stage
+ 0
All certificates
Send inquiry
Replies quickly
How does it work?
You can register for free as long as you are registering on behalf of a legal company related to the pharmaceutical industry
Search in the search bar the product that you’re looking for. We’ll show you an overview of all available suppliers. Use the filters to select the relevant suppliers only
Have you found interesting suppliers? Then it’s time to contact them. Use the send inquiry button and send them a message. You can send for each product, 3 inquiries per week
Suppliers get notified by Pharmaoffer that they’ve received a new inquiry. They will come back to you with their questions, certificates, and offer in the chat on Pharmaoffer. We will send you an email in case of any news
Does the supplier meet your quality and commercial requirements? Then you can place the order. Just follow the steps of our order module
Producer
+ 0
All certificates
Send inquiry
Replies slower than most
Send inquiry
Not active
Looking for Ruxolitinib 941678-49-5?
- Description:
- Here you will find a list of producers, manufacturers and traders of Ruxolitinib. You can sort by certificates such as GMP, FDA, CEP, Written Confirmation and more. Send inquiries for free and get in direct contact with the supplier of your choice.
- API | Excipient name:
- Ruxolitinib
- Synonyms:
- Cas Number:
- 941678-49-5
- DrugBank number:
- DB08877
- Unique Ingredient Identifier:
- 82S8X8XX8H
About Ruxolitinib
Here you will find more information about Ruxolitinib. Ruxolitinib is a janus-associated kinase inhibitor indicated to treat bone marrow cancer, specifically intermediate or high-risk myelofibrosis. FDA approved on November 16, 2011.
More information such as the structure, indication or toxicity is available on Drugbank, click the ID above.
Ruxolitinib manufacturers | traders | suppliers
We have 4 companies offering Ruxolitinib from 2 different countries.
Get in contact with the supplier of your choice:
- Shandong Octagon Chemicals Limited from China
- Apino Pharma Co., Ltd. from China
- Chongqing Huapont from China
- MSN Labs. from India
Let the supplier know whether you are looking for a product with a specific monograph such as EP (Ph. Eur.), USP, JP, BP or another quality. Or, whether you are looking for hydrochloride (HCl), anhydricum, base, micronisatum or a specific purity.
You can use the filters to find high-quality suppliers. For example, you can select GMP, FDA or ISO certified suppliers. Visit our FAQ page or use the chat box in the corner to get more information about Pharmaoffer.